| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $3.51B | -37.8% |
| Cost of Revenue | $2.15B | -42.6% |
| Gross Profit | $1.36B | -28.3% |
| R&D Expense | $16.0M | -55.5% |
| SG&A Expense | $1.17B | -27.0% |
| Operating Income | $185.9M | -35.6% |
| Interest Expense | $195.9M | -28.9% |
| Pre-tax Income | -$57.4M | -128.7% |
| Income Tax | $40.6M | +651.2% |
| Net Income | -$320.4M | -1707.7% |
| EPS (Basic) | -$0.91 | -1720.0% |
| EPS (Diluted) | -$0.91 | -1720.0% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.9M | +4.6% |
| Accounts Receivable | $376.2M | -32.5% |
| Inventory | $871.0M | -36.3% |
| Current Assets | $1.72B | -24.6% |
| Total Assets | $3.84B | -31.9% |
| Current Liabilities | $1.25B | -10.2% |
| Long-term Debt | $2.19B | -32.4% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $264.2M | -53.0% |
| Capital Expenditures | $37.9M | -14.0% |
| Investing Cash Flow | $813.0M | +3562.2% |
| Financing Cash Flow | -$1.05B | -80.4% |
| Free Cash Flow | $226.4M | -56.3% |
| Total Liabilities |
| $3.81B |
| -27.1% |
| Stockholders' Equity | $34.0M | -91.9% |